The size of the global Hospital Acquired Infection Control (HAIC) Market stood at USD 4.1 billion in 2023, and projections show that it is expected to burgeon to a value of USD 5.8 billion by 2033, based on findings in a research report published by Spherical Insights & Consulting. Major contributors to this growth encompass the likes of Olympus Corporation, Getinge AB, Xenex Disinfection Services, 3M Company, Sonoma Pharmaceuticals, Inc., Advanced Sterilization Products, and Stryker among others.
Hospital-acquired infections present a significant challenge in healthcare, with their control requiring diligent mitigation measures such as hygiene practices, well-maintained sterilization procedures, and the proper usage of personal protective equipment by healthcare personnel. Nevertheless, the increased volume of surgical procedures worldwide has consequently expanded the need for surgical equipment and thereby the hospital infection control services due to their critical role in ensuring effective and safe healthcare.
However, the risk of inadequate sterilization presents a serious obstacle to market growth, as poor cleaning practices increase the risk of infection transmission and patient mortality. Among the various specialties in the market, the consumables segment – comprising single-use infection control products – dominates with the highest market share, recording considerable growth courtesy of the soaring demand for disposable items such as gloves, masks, and gowns.
The HAIC market is further stratified into multiple end-user divides, including hospitals and intensive care units (ICUs), ambulatory surgical units, diagnostic centers, and others. Among these, the hospitals, and ICUs sector shows promise to record the fastest Compound Annual Growth Rate (CAGR) in the forecast period due to the high infection risks within such care settings.
Regionally, North America leads in terms of market size, attributable to the growth in the region’s chronic disease prevalence rate and the concomitant upsurge in hospital-acquired infections. Concurrently, the Asia Pacific region also shows a promising growth outlook due to increased infection rates, use of sterilization and disinfection equipment, and the expanding initiatives for infection control awareness and healthcare reforms.
Among the market players, Olympus Corporation, Getinge AB, Xenex Disinfector Services, 3M Company, Sonoma Pharmaceuticals Inc., STERIS, Advanced Sterilization Products, Stryker, Belimed AG, Becton, Dickinson and Company, Biomerieux Sa, Cantel Medical, Ethicon, Kimberly-Clark Corporation, Sterigenics International LLC, and others continue to actively drive forward industry growth.
Source: https://finance.yahoo.com/news/global-hospital-acquired-infection-control-020000058.html